A

Anima Research Center | Alken, Belgium

Research site

(Unclaimed)

Location

Alkerstraat 28, Alken, Limburg, Belgium

Site insights

Top conditions

Top treatments

Semaglutide

E2086

BI 1569912

JZP-258

BI 690517

Elinzanetant

Vicadrostat

REGN5381

Empagliflozin

Parent organization

This site is a part of Anima Research Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity (REDEFINE)

This study is testing whether CagriSema is safe and works well in adults with high blood pressure and excess body weight. Participants will receive C...

Not yet enrolling

Hypertension

Obesity

Drug: Semaglutide

Drug: Cagrilintide

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Enrolling

Obesity

Type 2 Diabetes

Drug: Cagrisema

Drug: Semaglutide

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of exce...

Enrolling

Narcolepsy

Drug: E2086

Drug: Placebo

Locations recently updated

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling

Hypertension

Cardiovascular Diseases

Drug: Placebo matching Vicadrostat

Drug: Vicadrostat

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight (OASIS 5)

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body wei...

Enrolling

Overweight

Obesity

Drug: Placebo

Drug: Semaglutide